TEMPLATE

Leaders in Learning: Publications of Faculty & Staff

Oncology: 1998-1999

BATTISTA, J.

Kelly, R.G., K. Jordan, and J. Battista. 1998. Optical CT reconstruction of 3D dose distributions using the ferrous-benzoic-xylenol (FBX) gel dosimeter. Medical Physics 25 (9): 1741-1750.

Tai, P., J. VanDyk, E. Yu, J. Battista, L. Stitt, and T. Coad. 1998. Variability of target volume delineation in cervical esophageal cancer. International Journal of Radiation Oncology, Biology, Physics 42 (2): 277-288.

BAUMAN, G.

Bampoe, J., G. Bauman, J.G. Cairncross, and M. Bernstein. 1999. Adult low grade gliomas: natural history, prognostic factors and timing of treatment. Low Grade Glioma. J. Rock, E. Shaw, J.G. Cairncross, and M. Rosenblum. Philadelphia: Lippincott-Raven. 135-148.

Bauman, G., P. Pahapill, D. Macdonald, B. Fisher, C. Leighton, and J.G. Cairncross. 1999. Low grade glioma: A measuring radiographic response to radiotherapy. Canadian Journal of Neurological Science 26: 18-22.

Bauman, G., V. Venkatesan, C.T. Ago, J.S. Radwan, A.R. Dar, and E. Winquist. 1998. Postoperative radiotherapy for Stage I/II seminoma: results for 212 patients. International Journal of Radiation Oncology, Biology, Physics 42 (2): 313-317.

Fisher, B., G. Bauman, C.E. Leighton, L. Stitt, J.G. Cairncross, and D. Macdonald. 1998. Low-grade gliomas in children: tumor volume response to radiation. Journal of Neurosurgery 88: 969-974.

Fisher, B., G. Bauman, C. Leighton, D. Macdonald, J.G. Cairncross, and L. Stitt. 1998. Pediatric low-grade gliomas: volume response to radiotherapy. Neurosurgical Focus 4 (4): 1-10.

Videtic, G.M., B. Fisher, F. Perera, G. Bauman, W. Kocha, M. Taylor, M. Vincent, E.A. Plewes, C.J. Engel, and L.W. Stitt. 1998. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. International Journal of Radiation Oncology, Biology, Physics 42 (2): 319-324.

BRAMWELL, V.

Levine, M., V. Bramwell, K. Pritchard, B. Norris, L. Shepherd, H. Abu-Zahra, B. Findlay, D. Warr, D. Bowman, J. Myles, A. Arnold, T. Vandenberg, R. Mackenzie, J. Robert, J. Ottaway, M. Burnell, C. Williams, and D. Tu. 1998. Randomized trial of cyclophosphamide, epirubicin, fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. Journal of Clinical Oncology 16 (8): 2651-2658.

Mertens, W.C., and V. Bramwell. 1998. Chemotherapy for Malignant Soft-Tissue Tumors (Chapter 46). Surgery for Bone and Soft-Tissue Tumors. M.A. Smith, and D. Springfield. Philadelphia, New York: Lippincott-Raven. 597-608.

Rusthoven, J., V. Bramwell, and B. Stephenson. 1998. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for treatment of cancer. Cancer Prevention & Control 2 (4): 179-190.

Seymour, L., V. Bramwell, L.A. Moran, and The Provincial Systemic Treatment Disease Site Group. 1999. Use of dexzaroxane as a cardioprotector in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. Cancer Prevention & Control 3 (2): 145-159.

CAIRNCROSS, J.G.

Cairncross, J.G. 1998. Cognition in survivors of high-grade glioma. Journal of Clinical Oncology 16 (9): 3210-3211.

Cairncross, J.G., K. Ueki, M.C. Zlatescu, D.K. Lisle, D.M. Finkelstein, R.R. Hammond, J.S. Silver, P.C. Stark, D. Macdonald, D.A. Ramsay, and D.N. Louis. 1998. Specific chromosomal losses predict chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. Journal of the National Cancer Institute 90: 1473-1479.

Cairncross, J.G., K. Ueki, M.C. Zlatescu, D.K. Lisle, D.M. Finkelstein, R.R. Hammond, J.S. Silver, P.C. Stark, D. Macdonald, D.A. Ramsay, and D.N. Louis. 1998. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. Journal of the National Cancer Institute 90 (19): 1473-1479.

DeAngelis, L.M., P.C. Burger, S.B. Green, and J.G. Cairncross. 1998. Malignant glioma: who benefits from adjuvant chemotherapy? Annals of Neurology 44 (4): 691-695.

Fisher, B., G. Bauman, C.E. Leighton, L. Stitt, J.G. Cairncross, and D. Macdonald. 1998. Low-grade gliomas in children: tumor volume response to radiation. Journal of Neurosurgery 88: 969-974.

Fisher, B., G. Bauman, C. Leighton, D. Macdonald, J.G. Cairncross, and L. Stitt. 1998. Pediatric low-grade gliomas: volume response to radiotherapy. Neurosurgical Focus 4 (4): 1-10.

Mintz, A.P., and J.G. Cairncross. 1998. Treatment of a single brain metastasis: the role of radiation following surgical resection. Journal of the American Medical Association 280 (17): 1527-1529.

Paleologos, N., and J.G. Cairncross. 1999. Treatment of oligodendroglioma: an update. Neuro-Oncology 1 (1): 61-68.

Perry, J.R., D.N. Louis, and J.G. Cairncross. 1999. Current treatment of oligodendrogliomas. Archives of Neurology 56 (4): 434-436.

Rock, J., M. Rosenblum, E. Shaw, and J.G. Cairncross. (Editors). 1999. Low Grade Glioma. Philadelphia: Lippincott-Raven.

Scott, J.N., N.B. Rewcastle, P.M. Brasher, D. Fulton, N.A. Hagen, J.A. MacKinnon, G. Sutherland, J.G. Cairncross, and P. Forsyth. 1998. Long-term glioblastoma multiforme survivors: a population-based study. Canadian Journal of Neurological Science 25 (3): 197-201.

Taylor, M., J. Perry, M.C. Zlatescu, A.O. Stemmer-Rachamimov, L.C. Ang, Y. Ino, M. Schwartz, L.E. Becker, D.N. Louis, and J.G. Cairncross. 1999. The hPMS2 exon 5 mutation and malignant glioma. Case report. Journal of Neurosurgery 90 (5): 946-950.

VanMeyel, D.J., O.H. Sanchez-Sweatman, N. Kerkvliet, L. Stitt, D.A. Ramsay, R. Khokha, A.F. Chambers, and J.G. Cairncross. 1998. Genetic background influences timing, morphology and dissemination of lymphomas in p53-deficient mice. International Journal of Oncology 13 (5): 917-922.

CHAMBERS, A.F.

Chambers, A.F. 1998. Metastasis Research Society V11 International Congress (Part II). ACTA Histochemica. San Diego, CA: 12-17.

Chambers, A.F., I.C. MacDonald, E.E. Schmidt, V.L. Morris, and A.C. Groom. 1999. Preclinical assessment of anti-cancer therapeutic strategies using in vivo videomicroscopy. Cancer and Metastasis Reviews 17: 263-269.

Hotta, H., S. Kon, Y.U. Katagiri, T. Tsukamoto, A.F. Chambers, and T. Uede. 1999. Detection of various epitopes of murine osteopontin by monoclonal antibodies. Biochemical and Biophysical Research Communications 257: 6-11.

Katagiri, Y.U., J. Sleeman, H. Fujii, P. Herrlich, H. Hotta, K. Tanaka, S. Chikuma, H. Yagita, K. Okumura, M. Murakami, I. Saiki, A.F. Chambers, and T. Uede. 1999. CD44 variants but not CD44s cooperate with ß1-containing integrins to permit cells to bind to osteopontin independently of RGD, thereby stimulating cell motility and chemotaxis. Cancer Research 59: 219-226.

Luzzi, K.J., I.C. MacDonald, E.E. Schmidt, N. Kerkvliet, V.L. Morris, A.F. Chambers, and A.C. Groom. 1998. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation, and limited survival of early micrometastases. American Journal of Pathology 153: 865-873.

Morris, V.L., E.E. Schmidt, I.C. MacDonald, A.C. Groom, and A.F. Chambers. 1999. Sequential steps in hematogenous metastasis of cancer cells, studied by in vivo videomicroscopy. Invasion and Metastasis 17: 281-296.

Naumov, G.N., S.M. Wilson, I.C. MacDonald, E.E. Schmidt, V.L. Morris, A.C. Groom, R.M. Hoffman, and A.F. Chambers. 1999. Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. Journal of Cell Science 112: 1835-1842.

Scott, J.A., M.L. Weir, S.M. Wilson, J.W. Xuan, A.F. Chambers, and D.G. McCormack. 1998. Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue. American Journal of Physiology 275: 2258-2265.

Teti, A., A.R. Farina, I. Villanova, A. Tiberio, A. Tacconelli, G. Sciotino, A.F. Chambers, A. Gulino, and A.R. Mackay. 1998. Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptide is RGD and cell shape change dependent. International Journal of Cancer 77: 82-93.

Tuck, A.B., F.P. O'Malley, H. Singhal, J.F. Harris, K.S. Tonkin, N. Kerkvliet, Z. Saad, G.S. Doig, and A.F. Chambers. 1998. Osteopontin expression in a group of lymph node negative breast cancer patients. International Journal of Cancer 79: 502-508.

Xuan, J.W., A.B. Tuck, S.M. Wilson, J.L. Chin, and A.F. Chambers. 1998. MMP-2 expression is associated with, but not sufficient for malignant conversion of murine LTA cells. Anticancer Research 18: 743-750.

CHIN, J.L.

DAR, A.R.

DIMATTIA, G.E.

DiMattia, G.E., R. Varghese, and G.F. Wagner. 1998. Molecular cloning and characterization of Stanniocalcin-related protein. Molecular and Cellular Endocrinology 146 (1-2): 137-140.

Gaasenbeek, M., B. Gellersen, and G.E. DiMattia. 1999. DNase I hypersensitivity analysis of non-pituitary human prolactin gene expression. Molecular and Cellular Endocrinology 152: 147-159.

Varghese, R., C.K.C. Wong, H. Deol, G.F. Wagner, and G.E. DiMattia. 1998. Comparative analysis of mammalian stanniocalcin genes. Endocrinology 139 (11): 4714-4725.

FISHER, B.

Byhardt, R., C. Scott, B. Sause, B. Emami, R. Komaki, B. Fisher, J. Lee, and C. Lawton. 1998. Response, toxicity, failure patterns and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small cell carcinoma of the lung. International Journal of Radiation Oncology, Biology, Physics 42 (3): 469-478.

Fisher, B., G. Bauman, C.E. Leighton, L. Stitt, J.G. Cairncross, and D. Macdonald. 1998. Low-grade gliomas in children: tumor volume response to radiation. Journal of Neurosurgery 88: 969-974.

Fisher, B., G. Bauman, C. Leighton, D. Macdonald, J.G. Cairncross, and L. Stitt. 1998. Pediatric low-grade gliomas: volume response to radiotherapy. Neurosurgical Focus 4 (4): 1-10.

Fisher, B., F. Perera, A. Cooke, A. Opeitum, and L. Stitt. 1998. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: Patterns of recurrence. International Journal of Radiation Oncology, Biology, Physics 42 (1): 117-123.

Vujovic, O., B. Fisher, and D. Munoz. 1998. Solitary intracranial plasmacytoma of the brain: Case report and review of management. Journal of Neuro-Oncology 39 (4): 47-50.

JORDAN, K.

Kelly, R.G., K. Jordan, and J. Battista. 1998. Optical CT reconstruction of 3D dose distributions using the ferrous-benzoic-xylenol (FBX) gel dosimeter. Medical Physics 25 (9): 1741-1750.

KOCHA, W.

Evans, W.K., W. Kocha, A. Gagliardi, A. Eady, and T.E. Newman. 1999. The use of gemcitabine in non-small cell lung cancer. Cancer Prevention & Control 3: 84-94.

Handfield-Jones, R., and W. Kocha. 1999. The role of medical organizations in supporting doctor-patient communication. Cancer Prevention & Control 3: 46-50.

Kelsen, D.P., R. Ginsberg, M.D. Thomas, F. Pajak, D.G. Sheahan, L. Gunderson, J. Mortimer, N. Estes, D.G. Haller, J. Ajani, W. Kocha, B.D. Minsky, and J.A. Roth. 1998. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. New England Journal of Medicine 339: 1979-1984.

McCarthy, G.M., J.D. Awde, H. Ghandi, M. Vincent, and W. Kocha. 1998. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncology 34: 484-490.

O'Connell, M.J., J.A. Laurie, M. Kahn, R.J.Jr. Fitzgibbons, C. Erlichman, C.G. Shepherd-Moertel, W. Kocha, R. Pazdur, H.S. Wieand, J. Rubin, A.M. Vokov, J.H. Donahue, J.E. Krook, and A. Figueredo. 1998. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. Journal of Clinical Oncology 16 (1): 295-300.

KOROPATNICK, J.

DeMoor, J., M. Vincent, O. Collins, and J. Koropatnick. 1998. RNA antisense to the thymidylate synthase (TS) mRNA translation initiation site induces TS gene transcription. Experimental Cell Research 243: 11-21.

MACDONALD, D.

Fisher, B., G. Bauman, C.E. Leighton, L. Stitt, J.G. Cairncross, and D. Macdonald. 1998. Low-grade gliomas in children: tumor volume response to radiation. Journal of Neurosurgery 88: 969-974.

Fisher, B., G. Bauman, C. Leighton, D. Macdonald, J.G. Cairncross, and L. Stitt. 1998. Pediatric low-grade gliomas: volume response to radiotherapy. Neurosurgical Focus 4 (4): 1-10.

Jakacki, R.I., C. Jamison, V.P. Mathews, D.K. Heilman, E. Dropcho, K. Cornetta, D. Macdonald, and D.A. Williams. 1998. Dose-intensification of procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cells in young patients with gliomas. Medical and Pediatric Oncology 31: 483-490.

MATTHEWS, T.W.

Lo, S.M., V. Venkatesan, T.W. Matthews, and J. Rogers. 1998. Tumour volume: Implications in T2/T3 glottic/supraglottic squamous cell carcinoma. Journal of Otolaryngology 27 (5): 247-251.

Sindwani, R., T.W. Matthews, J. Thomas, and V. Venkatesan. 1998. Epithelioid leiomyosarcoma of the larynx. Head and Neck 20 (6): 563-567.

MORRIS, V.L.

MYMRYK, J.S.

Grand, R.J., A.S. Turnell, G.G. Mason, W. Wang, A.E. Milner, J.S. Mymryk, S.M. Rookes, A.J. Rivett, and P.H. Gallimore. 1999. Adenovirus early region 1A protein binds to mammalian SUG1-a regulatory component of the proteasome. Oncogene 18: 449-458.

PERERA, F.

RADWAN, J.S.

RAYSON, D.

Rayson, D. 1999. Breaking bad news to our patients: Perils and possibilities. Journal of Pelvic Surgery 5 (1): 44-48.

Rayson, D. 1999. Tenju-Gann for all who need it. Cancer 85: 1197-1198.

Rayson, D., A.A. Adjei, V.J. Suman, L. Wold, and J.N. Ingle. 1999. Metaplastic breast cancer: Prognosis and response to systemic therapy. Annals of Oncology 10 (4): 413-420.

Rayson, D., P. Burch, and R. Richardson. 1998. Sarcoidosis and testicular cancer. Cancer 83: 337-343.

Rayson, D., C. Erlichman, V. Suman, P.C. Roche, L. Wold, J.N. Ingle, and J.H. Donohue. 1998. Molecular markers in male breast carcinoma. Cancer 83: 1947-1955.

Rayson, D., J.N. Ingle, and R. Pruthi. 1998. Thrombosis of the internal jugular vein: A rare manifestation of the hypercoagulability of malignancy. Cancer Investigation 16 (5): 319-321.

Rayson, D., J. Lust, A. Duncan, and D. Su. 1999. Scleromyxedema: A complete response to prednisone. Mayo Clinic Proceedings 74 (5): 481-484.

TAYLOR, M.

TORCHIA, J.

McInerney, E.M., D.W. Rose, S.E. Flynn, S. Westin, T.-M. Mullen, A. Krones, J. Inostroza, J. Torchia, R.T. Nolte, N. Assa-Munt, M.V. Milburn, C.K. Glass, and M.G. Rosenfeld. 1998. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes and Development 12: 3357-3368.

TUCK, A.B.

VANDENBERG, T.

Nabholtz, J.M., H.J. Seen, W.R. Beswoda, D. Melnychuk, L. Deschenes, J. Douma, T. Vandenberg, B. Rapoport, R. Rosso, V. Trillet-Lenoir, J. Drbal, A. Molino, J.W.R. Nortier, D.J. Richel, T. Nagykalnai, P. Siedlecki, N. Wilking, J.Y. Genot, P. Hupperets, F. Pannuti, D. Skarlos, E.M. Tomiak, M. Murawsky, M. Alakl, A. Riva, and M. Aapro. 1999. Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. Journal of Clinical Oncology 17 (5): 1413-1424.

VANDYK, J.

Fraas, B., K. Doppke, M. Hunt, G. Kutchener, G. Starkschall, R. Stern, and J. VanDyk. 1998. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning. Medical Physics 25 (10): 1773-1829.

VENKATESAN, V.

Lo, S.M., V. Venkatesan, T.W. Matthews, and J. Rogers. 1998. Tumour volume: Implications in T2/T3 glottic/supraglottic squamous cell carcinoma. Journal of Otolaryngology 27 (5): 247-251.

Sindwani, R., T.W. Matthews, J. Thomas, and V. Venkatesan. 1998. Epithelioid leiomyosarcoma of the larynx. Head and Neck 20 (6): 563-567.

VIDETIC, G.M.

VINCENT, M.

McCarthy, G.M., J.D. Awde, H. Ghandi, M. Vincent, and W. Kocha. 1998. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncology 34: 484-490.

Obrocea, M.M., M.A. Nassim, M.J. Molepo, F.H. Shirazi, G. Gallantt, H. Dulude, M. Vincent, D.J. Stewart, and R. Goel. 1998. In vitro carboplatin-mesna interaction in aqueous solution, human plasma and urine. Oncology Reports 5 (6): 1493-1498.

Vincent, M., R. Labianca, and P. Harper. 1999. Which 5-FU regimen? - the great debate. Anti-Cancer Drugs 10 (4): 337-354.

WINQUIST, E.

WONG, E.

Woo, M.K., D.J. Scora, and E. Wong. 1998. The regional Monte Carlo method: a dose calculation method based on accuracy requirement. Medical Physics 25 (10): 1866-1871.

YEE, S.P.

Lee, K.H., F.M.K. Tang, S.P. Yee, C. Schneider, and C. Brancolini. 1999. Gas2 is a multifunctional gene involved in the regulation of apoptosis and chondrogenesis in the developing mouse limb. Developmental Biology 207: 14-25.

YU, E.

Keyserlingk, J.R., P.D. Ahlgren, E. Yu, and N. Belliveau. 1998. Infrared imaging of the breast: Initial reappraisal using high-resolution digital technology in 100 successive cases of stage I and II breast cancer. Breast Journal 4 (4): 245-251.